PCC0208009 10 mg | 99.89%
TargetMol
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier Page
PCC0208009 (IDO-IN-2) is an IDO inhibitor extracted from patent WO/2015031295 A1, compound example 1.
More Information Supplier Page
Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.
More Information Supplier Page
Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contraction of rat and mouse colon induced by electrical field stimulation, nicotine and P2Y agonists. Antithrombotic; reduces platelet aggregation.
More Information Supplier Page
SC-560 is a member of the diaryl heterocycle class of cyclooxygenase (COX) inhibitors.
More Information Supplier Page
SC-560 is a member of the diaryl heterocycle class of cyclooxygenase (COX) inhibitors.
More Information Supplier Page
Delafloxacin (RX-3341, ABT-492) is a fluoroquinolone antibiotic agent. It has potent inhibitory against levofloxacin-resistant Streptococcus pneumoniae strains (MIC: 0.0078-0.125 μg/ml).
More Information Supplier Page